ReviewNuclear medicine and molecular imaging2025
Theranostics in the Indian Subcontinent: Opportunities, Challenges, and the Path Forward.
Review in Nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bridging the Gap in Theranostics: Where Do We Stand?Nuclear medicine and molecular imaging · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Theranostics, a combination of therapeutic and diagnostic approaches using molecular imaging and targeted radionuclide therapy, represents a significant advancement in personalized medicine. The Indian subcontinent, with its vast and diverse population, presents a unique landscape for the development and implementation of theranostics. This review critically examines the opportunities, challenges, and future directions of theranostics in the region. The large patient burden provides a fertile ground for research and clinical applications. Additionally, the presence of skilled manpower and established infrastructure offers a solid foundation for its advancement. However, financial constraints, uneven geographical distribution of expertise, and manpower shortages pose significant hurdles. This paper discusses strategies to address these challenges, emphasizing policy interventions, capacity building, and research initiatives to ensure equitable and sustainable growth of theranostics in the Indian subcontinent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.